证券日报网讯1月30日，九丰能源（605090）在互动平台回答投资者提问时表示，股价波动受多种因素 影响。公司致力于"成为最具价值创造力的清洁能源服务商"。上市以来，公司已形成清洁能源、能源服 务及特种气体的"一主两翼"业务发展格局，并持续强化各个业务板块的核心竞争力，持续开拓新的业务 增长点，经营业绩亦保持稳定增长。同时，公司积极维护全体股东的利益，上市以来持续实施现金分红 及股份回购，努力提升公司资本市场品牌价值。未来，公司将持续推进业务发展战略的实施，强化经营 管理工作，不断提升内在价值，并以《上市公司监管指引第10号——市值管理》为指引，不断优化市值 管理及投资者关系管理工作。 ...

Group 1 - The company emphasizes the importance of market capitalization management and is actively working to enhance its performance in the capital market [1] - Strategies employed by the company include improving operational performance, share buybacks, profit distribution, and investor relations management [1]

Core Viewpoint - Jilin Aodong (000623.SZ) expects a significant increase in net profit for the fiscal year 2025, projecting a range of 2.265 billion to 2.482 billion yuan, representing a growth of 46.00% to 60.00% compared to the previous year [1] Financial Performance - The net profit attributable to shareholders is projected to be between 2.265 billion and 2.482 billion yuan, with a year-on-year growth of 46.00% to 60.00% [1] - The net profit after deducting non-recurring gains and losses is expected to be between 2.069 billion and 2.287 billion yuan, reflecting a growth of 31.56% to 45.37% year-on-year [1] - The impact of non-recurring gains and losses on net profit is estimated to be approximately 195.6893 million yuan for 2025, compared to -21.5112 million yuan in the same period of 2024 [1] Strategic Focus - The company is focusing on value management and enhancing operational quality, adhering to its corporate values of "focusing on people and specializing in medicine" [1] - The implementation of a sales-driven policy centered on "large product groups and multiple product groups" is a key strategy for growth [1] - The company is pursuing a dual-driven development model of "pharmaceutical health + financial capital" to accelerate its growth [1]

证券日报网讯1月30日，中国中铁（601390）在互动平台回答投资者提问时表示，公司自上市以来一直 高度重视市值管理工作，通过不断完善公司治理、提升经营质量、充分开展资本运作、稳定分红、提高 信息披露和投资者关系管理水平等多种方式开展市值管理。未来，公司将继续致力提高经营质效，努力 加大分红频次，积极维护股价、回报股东。 ...

Core Viewpoint - Xuantai Pharmaceutical emphasizes the importance of market value management and aims for high-quality development to reward investors through improved performance [1] Group 1 - The company's stock price in the secondary market is influenced by various factors, including market conditions [1] - Xuantai Pharmaceutical is committed to enhancing operational management to achieve its development goals [1] - The company continuously focuses on high-quality growth to benefit its investors [1]

证券日报网讯 1月30日，好想你在互动平台回答投资者提问时表示，公司高度重视市值管理工作，并已 制定《2025年度估值提升计划》，通过聚焦主业、强化投资者回报等方式致力于提升内在价值。股价波 动受宏观经济、市场情绪等综合因素影响。公司对鸣鸣很忙持有的股权作为以公允价值计量且其变动计 入当期损益的金融资产，其价值的实现将为公司长期发展提供支持。公司经营合法合规，一切正常，不 存在应披露而未披露的重大风险，并将持续专注主业，以扎实业绩回报投资者信任。 （编辑 袁冠琳） ...

Group 1 - The company emphasizes the importance of market value management and has developed relevant management systems and work plans [1] - The company aims to actively maintain its market value by improving operational quality, standardizing corporate governance, enhancing information disclosure, and strengthening communication with investors [1]

Group 1: Business Development and Strategy - The company faced significant price reduction challenges in the automotive parts market due to intense competition, prompting a focus on internal management transformation and cost reduction strategies [2] - In 2025, the company implemented a cost control strategy that led to a substantial decrease in procurement expenses, resulting in a significant year-on-year increase in total profit and net profit attributable to shareholders [2] - The company plans to expand its business through mergers and acquisitions, targeting both automotive thermal management and other high-value automotive parts industries to enhance core competitiveness [3] Group 2: International Business Expansion - The company aims to strengthen its overseas business management and planning in 2026, with profitable operations already established in India, Thailand, Slovakia, and Morocco [4] - The Thai factory is experiencing rapid growth, and there are plans to build factories in ASEAN countries to tap into emerging markets [4] - In North America, the company expects significant improvements in performance due to better management practices and increased local production rates, addressing fluctuating tariff policies [5] Group 3: Energy Storage and Thermal Management - The energy storage thermal management business, initiated in 2021, faced challenges due to market conditions but is expected to recover significantly in 2025, particularly in the electric truck sector [6] - The company is considering entering the data center temperature control market to enhance its position in the water cooling market [6] Group 4: Market Value Management - The core of market value management is solid performance support and a clear future development outlook, with significant improvements in internal governance and business expansion since the acquisition by Changjiang Industrial Group [8] - The reduction of shareholding by major shareholders has alleviated market concerns, and the company plans to enhance market value management through diversified information disclosure and strengthened investor relations [8]

证券日报网讯1月30日，璞泰来（603659）在互动平台回答投资者提问时表示，公司一直非常重视市值 管理工作，致力于通过聚焦主业、改善经营、提升业绩等实际行动提升公司价值。 ...

南财智讯1月30日电，吉林敖东发布2025年度业绩预告，预计2025年全年归属于上市公司股东的净利润 为226503.39万元—248222.90万元，同比预增46.00%—60.00%；预计2025年全年归属于上市公司股东的 扣除非经常性损益的净利润为206934.46万元—228653.97万元，同比预增31.56%—45.37%。报告期内， 公司围绕市值管理，聚焦医药主业，持续提升经营质量，积极践行"专注于人、专精于药"的企业价值 观，实施"大品种群、多品种群"的销售拉动政策，坚持走"医药健康+金融资本"双轮驱动快速发展的道 路，按照年初制定的估值提升计划有序推进各项工作，业绩取得大幅增长主要原因是公司公允价值变动 收益及投资收益同比增加。2025年，预计非经常性损益金额对净利润的影响金额约为19568.93万元 （2024年同期为-2151.12万元）。 ...